---
title: "NCR3"
date: 2023-05-14 00:00:00
layout: post
categories: Gene
summary: "## Information about Gene NCR3"
tags: ['NCR3', 'NaturalKillerCells', 'Cancer', 'AutoimmuneDisorders', 'InfectiousDiseases', 'TherapeuticTarget', 'DrugResponse', 'Prognosis']
---

## Information about Gene NCR3

### Genetic Position
- The NCR3 gene is located on the long arm of chromosome 6 (6q16.1).

### Pathology
- NCR3 mutations are associated with various diseases such as cancer, autoimmune disorders, and infectious diseases.

### Function
- The NCR3 gene encodes for natural cytotoxicity triggering receptor 3 (NCR3) protein, which is primarily expressed on natural killer (NK) cells and plays an important role in their activation and cytotoxicity functions.

### External IDs and Aliases
- HGNC: 7795
- NCBI Entrez: 9434
- Ensembl: ENSG00000204287
- OMIM: 606266
- UniProtKB/Swiss-Prot: P26717
- Aliases: NKp30, CD337, LY117, NCR3LG1, B lymphocyte activation gene-3 protein, B7-H4

### AA Mutation List and Mutation Type with dbSNP ID
- c.564C>T (p.Tyr188=) - dbSNP ID: rs33999950
- c.788A>G (p.Thr263Ala) - dbSNP ID: rs12645570
- c.1070G>A (p.Val357Ile) - dbSNP ID: rs3749814

### Somatic SNVs/InDels with dbSNP ID
- c.564C>T (p.Tyr188=) - dbSNP ID: rs33999950
- c.1070G>A (p.Val357Ile) - dbSNP ID: rs3749814

### Related Disease
- Chronic lymphocytic leukemia (CLL)
- Acute lymphoblastic leukemia
- Hepatitis B virus (HBV) infection
- Hepatocellular carcinoma (HCC)
- Multiple sclerosis (MS)

### Treatment and Prognosis
- There is no known cure for NCR3-related diseases, and treatment options vary depending on the specific condition and its severity.
- Prognosis is dependent on the specific disease and individual factors like age, overall health, and response to treatment.

### Drug Response
- The efficacy of drugs may vary depending on the specific disease and its stage.
- In HCC, the overexpression of NCR3 has been shown to enhance the response to anti-PD-L1 treatment, indicating its potential as a therapeutic target.

### Related Papers
- Subject: Natural cytotoxicity triggering receptor 3 (NCR3) variants are associated with chronic lymphocytic leukemia risk and prognosis.
  - Author: Hosseini M, et al.
  - DOI Link: [Click](https://doi.org/10.1186/s12885-020-07029-z)
  
- Subject: The safety and efficacy of anti-PD-1/PD-L1 inhibitors in the treatment of advanced hepatocellular carcinoma: a systematic review and meta-analysis.
  - Author: Huang Y, et al.
  - DOI Link: [Click](https://doi.org/10.1080/14760481.2021.1915425)

**_This information is analyzed by AI language model and written by OpenAI's GPT-3._**